OLIVIER LICHTARGE to Protein Kinase Inhibitors
This is a "connection" page, showing publications OLIVIER LICHTARGE has written about Protein Kinase Inhibitors.
Connection Strength
0.043
-
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence. Mol Cancer Ther. 2015 Feb; 14(2):608-19.
Score: 0.043